![DASH™ Rapid PCR System DASH™ Rapid PCR System](https://www.nuclein.com/wp-content/uploads/2023/07/mobile_dash.png)
![FDA EUA – AUTHORIZED FDA EUA - AUTHORIZED](https://www.nuclein.com/wp-content/uploads/2023/07/FDA-EUA-AUTHORIZED.png)
DASH™ Rapid PCR System
is a simple, affordable, point-of-care platform that performs sample-to-answer PCR in 15 minutes
![](https://www.nuclein.com/wp-content/uploads/2023/07/Vector-Smart-Object-1.png)
Central Lab Quality
Limit of Detection (LOD) of 150 cp/mL1
![](https://www.nuclein.com/wp-content/uploads/2023/07/Vector-Smart-Object-2.png)
Simple to Use
Ideal for CLIA-waived environment
![](https://www.nuclein.com/wp-content/uploads/2023/07/vector-15mins.png)
Sample-to-answer
PCR in 15 minutes
Wide range of
sample types*
![](https://www.nuclein.com/wp-content/uploads/2023/07/vector-1min.png)
Hands on time
1 minute
![](https://www.nuclein.com/wp-content/uploads/2023/07/vector-file.png)
Small, robust,
intuitive (4” wide)
Best-in-class
sensitivity1
Multiplex-
capable*
![](https://www.nuclein.com/wp-content/uploads/2023/07/quote-left-removebg-preview.png)
![](https://www.nuclein.com/wp-content/uploads/2023/07/quote-right-removebg-preview.png)
Chad Achenbach, M.D.
Associate Director of Infectious Diseases at Feinberg School of Medicine,
Northwestern University, Chicago, IL.
Fierce BioTech – 10/3/22
Clinical Trial Data1
The DASH™ Rapid PCR System “was accurate, easy to
use, and provided fast results (approximately 15
minutes) in real-life clinical settings”
![](https://www.nuclein.com/wp-content/uploads/2023/07/done-removebg-preview.png)
![](https://www.nuclein.com/wp-content/uploads/2023/07/done-removebg-preview.png)
Concordant results for 307 tests1
![](https://www.nuclein.com/wp-content/uploads/2023/07/done-removebg-preview.png)
![](https://www.nuclein.com/wp-content/uploads/2023/07/done-removebg-preview.png)
![](https://www.nuclein.com/wp-content/uploads/2023/07/done-removebg-preview.png)
to Cepheid GeneXpert
1 See Technology Page for details
*This product has not been FDA cleared or approved. It has been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Additional indications beyond SARS-CoV-2 will require separate FDA clearances and are not commercially available at this time.